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Most aneurysms are commonly associated with a
thick mural thrombus, whereas oversized prosthetic
grafts deposit a laminated mural thrombus, which
shapes its lumen down to a normal-size channel.1,2
After being narrowed down to the size of runoff, the
caliber remains fairly constant as long as the hemo-
dynamic conditions maintain stability, which sug-
gests sufficient antithrombogenicity of the fibrin
flow surface with a physiologic shear rate. Some
reports have suggested that the fibrin flow surface
may acquire antithrombogenicity3-5; however, these
reports did not provide any clues concerning the
substantial mechanism that explains the increased
antithrombogenicity.
In the last three decades, the activation pathways
of plasminogen and its inhibitors have been exten-
sively investigated.6,7 These studies have demon-
strated that when fibrin is digested by plasmin, the
binding of both plasminogen and tissue plasmino-
gen activator (tPA) to fibrin increases. Thus, a 
plasmin-digested fibrin enhances the activation rate
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of plasminogen8,9 and potentiates the fibrinolytic
process. Sakharov and Rijken10 recently reported in
their experimental model that the generation of sur-
face-associated plasminogen-binding sites during
thrombolysis results in a strikingly high plasminogen
concentration at the surface of a lysing clot. Despite
this background, however, few reports have focused
on the fibrinolytic activity on the flow surface of
mural fibrin in the human arterial system.3,4,11
To identify the mechanisms responsible for the
antithrombogenicity suggested by the experimental
and clinical findings, we investigated the fibrinolytic
activity of the mural thrombus of aneurysms and
prosthetic grafts in humans.
METHODS
Between May 1995 and April 1998, the full-
thickness mural thrombi of unruptured aortic
aneurysms and the pseudointima of synthetic vascu-
lar grafts were obtained from 12 unselected patients
who underwent elective surgery (11 men and one
woman; age range, 55-78 years; mean age, 68.5 ±
6.9 years). These included five distal aortic arch
aneurysms, four abdominal aortic aneurysms, and
three patent synthetic vascular grafts: two knitted
Dacron grafts with well-healed inner capsules
(Bionit II, C.R. Bard, Billerica, Mass, and Gelsoft,
Vascutek, Ayr, United Kingdom) and an ovine
biosynthetic graft (Omniflow, Bio Nova, North
Melbourne, Australia), which is a composite vascular
prosthesis composed of glutaraldehyde-tanned ovine
tissue and polyester mesh tubing. These grafts were
removed during revision operations for graft com-
plication at 8, 28, and 36 months after implantation.
The indications for revision included distal anasto-
motic stenosis, graft infection of the aortofemoral
bypass graft, and an aneurysm of the femoro-
popliteal bypass graft.
Specimen preparation. The aortic aneurysms
were opened longitudinally after circulatory arrest
was established or after crossclamping of the
infrarenal aorta, and the mural fibrin masses, which
had a thickness of 1 to 4 cm, were obtained en bloc
from the lumen of the aorta. The synthetic grafts
were crossclamped after 1 mg/kg of heparin was
administered, and a disease-free segment with a
length of 5 cm was dissected by means of the no-
touch technique. These fibrin specimens were
immediately rinsed gently, then frozen in normal
saline at –80°C for later examinations. The frozen
fibrin specimens were defrosted in normal saline at
37°C, cross-sectioned, and divided into two to ten 2
mm-thick layers, according to the thickness of the
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thrombus. The samples obtained from each layer
were subjected to sodium dodecyl sulfate polyacry-
lamide gel electrophoresis (SDS-PAGE)/ immuno-
blot, whereas the remaining specimens were also
subjected to histologic examination, scanning elec-
tron microscopy (SEM), and immunohistochemical
analysis.
Preparation of plasmin-treated fibrin plates.
Cross-linked fibrin plates were prepared by dissolv-
ing 100 mg human fibrinogen (Yoshitomi
Pharmacy, Osaka, Japan) in 50 mL phosphate
buffered saline (PBS; 50 mmol/L, pH 7.5). This
fibrinogen preparation contained approximately 10
U/mg of factor XIII (manufacturer’s data). A 0.2-
mL aliquot of the solution was placed on a plate and
spread uniformly, and 10-µL of 20 U/mL thrombin
solution (Mochida Pharmacy, Osaka, Japan) con-
taining 20 mmol/L CaCl2, 2 mmol/L MgCl2, and
5 mmol/L HEPES buffer (pH 7.4; Sigma, Tokyo,
Japan) with 150 mmol/L NaCl was added. The
mixture was incubated for 24 hours at 37°C, and a
cross-linked fibrin plate was then obtained.
To assist in the possible identification of the 
fibrin digestion products of our human specimens,
we exposed the fibrin plates to various proteolytic
enzymes, including plasmin, elastase, and a neu-
trophil extract. For the analysis of plasmin digestion,
1 mL of 0.01 U/mL plasmin solution (Protogen
AG, Läufeltingen, Switzerland) was applied to 0.4
mg of the fibrin plate for either 1 or 3 hours, and it
was rinsed with normal saline to remove residual
plasmin. For elastase digestion analysis, 0.01 U/mL
of elastase (Cosmo Bio, Tokyo, Japan) was applied
to 0.4 mg of the fibrin plate. Neutrophils were sep-
arated by means of isopyknic centrifugation by using
a Ficoll-Paque (Amersham Pharmacia Biotech,
Uppsala, Sweden).12 The extract of neutrophil solu-
tion contained cathepsin G, neutrophil elastase, and
other proteases. The mixture was incubated for 1
hour at 37°C, and each protease that had been
applied to the fibrin plates was then discarded; the
remaining fibrin sample was then rinsed with normal
saline and analyzed by means of SDS-PAGE. The in
vitro data obtained from the plasmin-treated fibrin
plate were used to identify the specific bands of the
analyzed mural fibrin samples.
Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis/immunoblot.  The fibrin plate sam-
ples (0.4 mg) were placed in an incubation well con-
taining 0.5 mL of 10 mmol Tris/HCl/buffer (pH
7.4) with 2% SDS, 9 mol/L urea, and 2% mercap-
toethanol (fibrin-dissolving buffer) and were incubat-
ed in a shaker for 18 hours at 60°C. Each dissolved
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fibrin sample was subjected to SDS-PAGE (gel con-
centration at 4%-20%) (Tefco, Tokyo, Japan), in
accordance with the method reported by Laemmli.13
In the analysis of the samples, 20- to 28-mg wet-
weight fibrin samples were obtained from several lay-
ers of each mural fibrin sample. Likewise, each sample
was placed in an incubation well containing 1 mL of
the fibrin-dissolving buffer, incubated in the same
manner, and subjected to SDS-PAGE. Two-percent
mercaptoethanol was added to disrupt the S-S bind-
ing sites, so that the subunits composing the fibrin
molecule could be examined. The protein bands were
stained with Coomassie Blue containing a mixture of
H2O-methanol-acetic acid (10:8:2, vol/vol/vol) and
then destained with the mixture of H2O-methanol-
acetic acid solution (19:7:2, vol/vol/vol). 
We further examined the specificity of the bands by
using immunoblot analysis14 (Clear blot P membrane,
ATTO, Tokyo, Japan), with peroxidase-labeled anti-
human fibrinogen antibody (PPO56, The Binding
Site, Birmingham, United Kingdom). The column
was stained with a 1:100 dilution of the antifibrino-
gen antibody and made visual with 4-chloro-1-
naftol (Tokyo Chemical Industry, Tokyo, Japan).
Histologic examination and scanning elec-
tron microscopy. The mural thrombi from the
aneurysms were cross-sectioned and divided into
two to three layers (surface, middle, outer),
whereas the vascular grafts were cross-sectioned,
longitudinally sectioned, or both. Each sectioned
specimen was fixed with 10% neutral buffered for-
malin solution for 24 hours at 4°C. After fixation,
the specimens were embedded in paraffin, sec-
tioned, and stained with the hematoxylin-eosin,
azan, phosphotungstic acid-hematoxylin, and
Masson trichrome methods. 
Fig 1. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the cross-linked fibrin plates after
limited digestion with various enzymes. A, 25- and 27-kd bands (arrows) were recognized specifically
after the plasmin digestion. 1, Untreated fibrin; 2, plasmin digestion for 5 minutes; 3, plasmin diges-
tion for 15 minutes; 4, plasmin digestion for 30 minutes; 5, plasmin digestion for 60 minutes; M, mol-
ecular-weight standard. B, 36- and 43-kd bands appeared after digestion with extraction of neutrophil
solution for 60 minutes (lane 3, arrows). 1, Plasmin digestion; 2, elastase digestion.
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The surfaces of the fibrin specimens were
observed with SEM. Each specimen was fixed
overnight with 1% glutaraldehyde in PBS. After rins-
ing in PBS, the specimen was postfixed in 1% osmi-
um tetroxide, dehydrated, dried in the critical point
dryer, and sputter-coated with platinum.
Immunohistochemistry.  To investigate the dis-
tribution of fibrinolytic activity in the specimens, we
performed immunohistochemical analysis, by using
the labeled avidin-biotin immunoperoxidase tech-
nique, with antihuman plasmin/plasminogen and
anti-tPA mouse monoclonal antibodies (murine
MAb #3642, American Diagnostica, Greenwich,
Conn, and PAM-1, Biopool AB, Umeå, Sweden,
respectively), and antifibrin degradation product (D-
dimer) monoclonal antibody (2F7#84911, Celsus
Laboratories, Cincinnati, Ohio) as the primary anti-
bodies. These three types of antibodies were applied
to three different continuous sections (ie, one sec-
tion for each antibody), and a negative control was
used for each staining.
After deparaffinization of the paraffin sections,
blockage of endogenous peroxidase activity was per-
formed for 30 minutes with 0.3% H2O2 in methanol
as a diluent; the sections were then incubated in a
1:200 or 1:500 dilution of each primary monoclon-
al antibody for 60 minutes at room temperature.
After being washed twice with PBS for 5 minutes
each, the sections were incubated in biotinylated
secondary antibody for 30 minutes at room temper-
Fig 2. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis/immunoblot of the mural fibrin
mass obtained from an aortic arch aneurysm. A, 25- and 27-kd bands were more clearly visible in lane
1 when compared with those in lanes 2 and 3, confirming that the flow surface of the mural fibrin had
been digested by endogenous plasmin. A 43-kd band was recognized in lanes 2 to 3, suggesting diges-
tion with proteases derived from neutrophils. B, Immunoblot, revealing that all specific protein bands
that appeared in Fig 3A were fibrin fragments. 1 through 3, Mural fibrin; 1, flow surface; 2, middle
layer; 3, outer layer; 4, plasmin treated experimental cross-linked fibrin; M, molecular-weight standard.
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ature. Finally, they were made visual by means of the
avidin-biotin-peroxidase-labeling system. Positive
staining with 0.1% diaminobenzidine tetrahy-
drochloride solution (0.2% H2O2, 0.05 mol tris
buffer, pH 7.2) appeared brown. The sections were
counterstained with hematoxylin.
RESULTS
Immunoblot analysis of fibrin digestion by
plasmin, elastase, and neutrophil extraction.  In
the SDS-PAGE of the fibrin plates before digestion,
bands were detected at 55, 100, and more than 170
kd, consistent with β-chain, γ-dimer chain, and α-
polymer chains, respectively. In the limited digestion
Fig 3. Immunohistochemistry for plasmin/plasminogen
and tissue plasminogen activator in the mural thrombus of a
graft aneurysm. Increased immunoreactive layers (between
arrows) for plasmin/plasminogen (A) and tissue plasmino-
gen activator (B) were recognized at the flow-surface, show-
ing specific accumulation of plasminogen/tPA on the flow
surface of the mural thrombus. Magnification, 40×; bar, 100
µm in A and B. C, The brown layer represents fibrin degra-
dation product (D-dimer) accumulation, revealing ongoing
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by each enzyme, 25- and 27-kd bands were recog-
nized specifically only after the plasmin treatment
(Fig 1), suggesting that these bands represented the
fibrin fragments produced by the plasmin digestion.
The 36- and 43-kd bands were observed when the
neutrophil extraction was applied to the fibrin plate.
Immunoblot analysis of specimens.  In the SDS-
PAGE for the mural thrombi obtained from the aorta
or pseudointima of the grafts, several bands were
observed. According to the analysis of the experimen-
tal fibrin plates, the bands that appeared at 55, 100,
and more than 170 kd were consistent with the β-
chain, γ-dimer chain, and α-polymer chains, respec-
tively, suggesting that the mural thrombus of
aneurysms is mainly composed of cross-linked fibrin
polymer. The bands at 25 and 27 kd were most promi-
nent in sections near the flow surface layer (Fig 2, A).
All the proteins that appeared in the SDS-PAGE of the
mural thrombi were demonstrated by means of the
immunoblot to be fibrin fragments (Fig 2, B). The
presence of a 43-kd band was more prominent in the
middle and outer layers of the mural thrombus. No
qualitative differences were found among the results of
the SDS-PAGE/immunoblot in the samples obtained
from the abdominal aortic aneurysms, thoracic aortic
aneurysms, and vascular graft lining.
Fig 4. Immunohistochemistry for plasmin/plasminogen, tissue plasminogen activator, and fibrin
degradation product (D-dimer) in a knitted Dacron graft with a well-healed inner capsule retrieved 8
months after implantation. A, The flow surface of the graft. B, Scanning electron microscopy for the
flow surface showing compact fibrin. Magnification, 35,000×; bar, 857 nm. Increased immunoreac-
tivities (between arrows) for plasmin/plasminogen (C).
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Histologic examination, scanning electron
microscopy, and immunohistochemistry. The 
samples obtained from the aneurysm wall thrombus
were stained uniformly; however, the middle and
outer layers had a variable staining pattern, suggest-
ing exposure to various enzymes for a long period.
The flow surface layer was revealed by means of SEM
to consist of compact fibrin. Positive uniform stain-
ing with a thickness of approximately 10 to 400 µm
at the flow surface was demonstrated by means of
immunohistochemical staining for plasmin/plas-
minogen, tPA, and D-dimer (Fig 3). This pattern of
staining, with high accumulations of both plasmino-
gen and tPA and with D-dimer as a consequential
product of fibrinolysis, is consistent with our 
hypothesis. 
Fig 4 Cont’d. Tissue plasminogen activator (D), and D-dimer (E) on the fibrin lining of the pseudoin-
tima, suggesting fibrinolysis on the flow surface. Magnification, 40×; bar, 100 µm in C through E.
D
E
The formation of well-healed pseudointima was
demonstrated by means of hematoxylin-eosin stain-
ing of the graft samples; however, the flow surface
was lined with a thin compact fibrin layer, the obser-
vation of which was confirmed by means of both his-
tologic examination and SEM (Fig, 4, A and B).
Accumulations of plasmin/plasminogen and tPA,
with a thickness of 10 to 20 µm, and an increased
immunoreactivity for D-dimer, with a thickness of 20
to 50 µm, was demonstrated by means of immuno-
histochemical analysis of the fibrin lining (Fig 4, C,
D, and E), suggesting fibrinolysis on the flow surface.
DISCUSSION
More than 40 years ago, Todd15 and Astrup16
recognized that the intima of vessels possessed
intrinsic fibrinolytic activity. Almost 20 years later,
Levin and Loskutoff17 demonstrated that cultured
bovine endothelial cells had the capacity to produce
and bind both urokinase and tPA, and Yao et al11
demonstrated fibrinolytic activity on the luminal sur-
face of unoccluded Dacron grafts. Underwood et al
observed that the intrinsic fibrinolytic activity ranked
in the order of endarterectomy cores, then internal
mammary artery, then saphenous vein18 and that the
impaired activity may contribute to early graft
thrombosis.19 These observations suggest that fibri-
nolytic activity on the flow surface plays an impor-
tant role in maintaining the antithrombogenicity of
the vessels.
Fibrinolysis in the vascular system is regulated by
various pathways of plasminogen to plasmin.6,7,20
The major plasminogen activator inhibitor (PAI),
PAI-1, is released by endothelial cells and is inacti-
vated rapidly by incorporation into the plasminogen
activator. A constant process of fibrinolysis and clot
formation exists on the endothelial surface, which is
regulated by the balance of tPA and PAI-1. The plas-
ma concentration of PAI-1 in normal conditions is
only approximately 20 ng/mL,21 whereas the bind-
ing of plasminogen and tPA increases progressively
as a function of the degradation of the fibrin sur-
face.22 When fibrin is treated with plasmin, the bind-
ing of plasminogen to the superficial layer of a fibrin
clot markedly increases.9,23-26 The binding of tPA to
fibrin also increases after limited plasmin digestion,
depending on the generation of carboxyl-terminal
lysin residues.27
The enhancing mechanism of the fibrinolysis on
the fibrin surface has been studied in experimental fi-
brin clot models. In the presence of fibrin, tPA strik-
ingly enhances the activation rate of plasminogen.8
Furthermore, because the inhibition of fibrinolytic
enzymes proceeds only in the fluid phase,22,28 PAI-1 is
unable to inhibit fibrin-bound tPA in a fibrin layer. On
the basis of these reports, we speculated that, although
PAI-1 inactivates tPA only on the fibrin surface,
impairing further degradation of the fibrin, PAI-1 on
the fibrin surface may be insufficient for continued
inactivation of the tPA in normal conditions. Thus, the
fibrinolysis proceeds slowly. In the current study, the
high accumulation of plasminogen/tPA on the mural
fibrin surface was recognized, but it was difficult to
prove the presence of ongoing fibrinolysis conclusive-
ly. The accumulation of D-dimer, which is an impor-
tant marker for fibrinolysis of the thrombus, was
demonstrated by means of immunohistochemistry.29
Although the detailed regulation mechanism of tPA
and PAI-1 at the interface remains unclear, we consid-
ered the accumulation of D-dimers, although indirect,
to be evidence of ongoing fibrinolysis in the plasmino-
gen/tPA-rich layer.
The initial digestive products of fibrin treated
with plasmin were demonstrated by means of the
SDS-PAGE to be proteins of 25 and 27 kd, which
Vries et al27 and Pizzo et al30 also recognized as
aminoterminal fragments of the α-chains. The pres-
ence of these bands in the mural fibrins, which were
most prominent in sections near the flow surface
layer, suggested the presence of fragments of the α-
chains and was consistent with the hypothesis that
the mural fibrin was digested by the endogenous
plasmin. Because the human fibrinogen used in this
study contained a significant amount of plasminogen
and tPA, the untreated fibrin plate was gradually
digested by the inherent plasmin. This explains the
presence of a dim 27-kd band in the SDS-PAGE of
the untreated fibrin plate (Fig 1, A). 
Elastase and cathepsin G, which were identified
as the major fibrinolytic enzymes of leukocytes,31 are
possible contributors of other enzymes to fibrinoly-
sis. Plasminogen is a substrate of elastase and cathep-
sin G, and the product of its limited digestion is
miniplasminogen. Kolev et al32 performed a quanti-
tative comparison of the degradation of cross-linked
fibrin with plasmin, miniplasmin, neutrophil leuko-
cyte elastase, and cathepsin G; no changes in their
contribution to fibrinolysis were observed, whereas
the most efficient fibrinolytic enzymes were found
to be miniplasmin and elastase when the plasmin
inhibitor was cross-linked to fibrin. In this study, the
presence of a 43-kd band, which was more promi-
nent in the middle and outer layers of the mural
thrombus, suggested that the fibrin of the middle
and outer layers is digested not only by plasmin, but
also by proteases derived from neutrophils.
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In the analysis of vascular grafts, it is essential to
obtain the samples from patent grafts. When graft
occlusion occurs, the lumen is occupied by thrombi,
which may abruptly alter the characteristics of the
flow surface. Yao et al11 reported that fibrinolytic
activity could be measured only in vascular grafts
that had maintained patency at the time of harvest-
ing. However, because of the obvious difficulties in
obtaining patent grafts from living patients, the
number of specimens available for the evaluation was
limited.
In conclusion, the results of this study are con-
sistent with our hypothesis that the fibrin surface of
aneurysms or prosthetic grafts has a thin plasmino-
gen and tPA-rich layer, formed by digestion with
endogenous plasmin. This potentiates the fibrinolyt-
ic process on the flow surface and may, in part, be
responsible for maintaining its antithrombogenicity.
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